Biotech5 hours ago
Almirall Highlights Breakthrough Dermatology Evidence and Innovation at EADV 2025
At the 34th EADV Congress, Almirall showcases 44 abstracts, two symposia, and an interactive space, highlighting lebrikizumab’s efficacy in atopic dermatitis, tildrakizumab in psoriasis, and tirbanibulin...